Loading...
Market
Impact on public trust in COVID-19 vaccines from Pfizer document release by end of 2025?
2
Resolution / Starting Odds
Increase trust • 25%
Decrease trust • 25%
No significant change • 25%
Mixed impact • 25%
Public opinion polls and surveys conducted by reputable organizations
Story
U.S. Judge Orders FDA to Release More Pfizer COVID-19 Vaccine Trial Documents for Transparency
Dec 6, 2024, 09:24 PM
A U.S. District Judge Mark Pittman has ordered the FDA to release an additional million pages of documents from Pfizer's COVID-19 vaccine trials. This decision comes after the FDA's unsuccessful attempt to end a public records lawsuit, which sought transparency on the authorization of the vaccines. The court's order aims to provide greater public access to the data behind the vaccine's authorization, following previous efforts to expedite the release of such documents. The documents in question were initially sought to be hidden by the FDA, marking a significant win for transparency.
View original story
Similar markets
Increased trust in vaccines • 25%
Decreased trust in vaccines • 25%
Increased demand for transparency • 25%
Indifference • 25%
Increased transparency and trust • 25%
Legal challenges against FDA • 25%
Policy changes in vaccine approval • 25%
No significant impact • 25%
Increased trust • 25%
Decreased trust • 25%
No significant change • 25%
Mixed responses • 25%
Increased trust in mRNA vaccines • 25%
Decreased trust in mRNA vaccines • 25%
Trust remains unchanged • 25%
Mixed opinions • 25%
FDA • 25%
Pfizer • 25%
Public Health Organizations • 25%
No major impact on any organization • 25%
Increase • 25%
Decrease • 25%
Remain the same • 25%
Uncertain/Varied • 25%
Independent Researchers • 25%
Mainstream Media • 25%
Government Agencies • 25%
Pfizer • 25%
Increased vaccine hesitancy • 25%
No significant change • 25%
Increased trust in vaccines • 25%
Public divided • 25%
0-25% • 25%
26-50% • 25%
51-75% • 25%
76-100% • 25%
Increased trust • 25%
Decreased trust • 25%
No significant change • 25%
Other outcome • 25%